In addition, dysregulated TGF-β/activin/nodal signaling enables the activation of extracellular-signal-regulated kinase, nuclear factor-κB and Rho kinase pathways, which may also promote PAH [23]. Here, TGFB1 is linked to pulmonary arterial hypertension.